(1)
An Evaluation of the Pharmacokinetics and Virtual Screening of Highly Effective Hybrid Compounds for Alzheimer’s Disease. J Environ Bioremed Toxicol 2024, 7 (2), 63-74. https://doi.org/10.54987/jebat.v7i2.1046.